The metabolic syndrome in young Korean women with polycystic ovary syndrome

Park, Hwi Ra; Choi, Youngju; Lee, Hye Jin; Oh, Jee Young; Hong, Young Sun; Sung, Yeon Ah

doi:10.1016/j.diabres.2007.01.065

Cited by 55 publications

(53 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, in several studies in US, the prevalence of MS was 33.4-46% according to NCEP-ATP III criteria (12,25). In India and Brazil, this prevalence rates were 37.9% and 28.4% (13,17), respectively. In contrary, in several European countries, the prevalence rates of MS in PCOS women are lower than our results, like 11.6% in Turkey (18), 8.2% in southern Italy according to ATPIII criteria (19) and 1.6% in the Czech Republic (26).…”

Section: Discussionmentioning

confidence: 99%

“…Many of the metabolic abnormalities of PCOS patients overlap with components of MS. The prevalence rates of MS in PCOS women vary among different countries and ethnicities as follows: 43-46% in America (11,12), 37.9% in India (13), 35.3% in Thailand (14), 28.4% in Brazil (15), 16.8% in China (16), 14.5% in Korea (17), 11.6% in Turkey (18) and 8.2% in Southern Italy (19). These differences in prevalence rates of MS in PCOS patients in different countries may be depended to several factors, like age, BMI, and race of patients as well as different approaches to define MS and PCOS.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Metabolic syndrome in infertile women with polycystic ovarian syndrome

Madani

Hosseini

Ramezanali

et al. 2016

Arch. Endocrinol. Metab.

View full text Add to dashboard Cite

Objective: The aim of the present study was to determine the prevalence of metabolic syndrome (MS) in infertile Iranian women with polycystic ovary syndrome (PCOS) using the ATPIII criteria. Subjects and methods: In this cross-sectional study, 624 women with PCOS were enrolled at a tertiary referral center in Tehran, Iran, between April, 2012 and March, 2013. Diagnosis of MS was according to ATPIII criteria. Also, we divided PCOS patients into following two main groups: (i) with MS (n = 123) and (ii) without MS (n = 501), and then compared variables between two groups. Results: The mean age, body mass index (BMI) and waist circumference were 28.6 ± 4.3 years, 26.7 ± 3.7 kg/m 2 and 85.2 ± 8.7 cm, respectively. The prevalence of MS was 19.7%. Our findings showed that age, BMI, waist circumference and all metabolic parameters were higher in PCOS women with MS than related values in those without MS. The most and least prevalent forms of MS were low level of high density lipoprotein-cholesterol (HDL-C) and hypertension, respectively. Conclusion: It seems the prevalence of metabolic syndrome in our country isn't as high as western countries. The prevalence rate of MS increased with age and BMI. One of the major cardiovascular risk factors, low level of HDL-C, is the most prevalent metabolic abnormality in our participants.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Metabolic syndrome in infertile women with polycystic ovarian syndrome

Madani

Hosseini

Ramezanali

et al. 2016

Arch. Endocrinol. Metab.

View full text Add to dashboard Cite

show abstract

“…Patients with PCOS often have complications associated with dyslipidemia, diabetes mellitus/impaired glucose tolerance, and hypertension, and are therefore at increased risk of having MetS (8)(9)(10). The prevalence of MetS in PCOS patients varies among different ethnicities and has been reported to be w43.0-47.3% in America (11)(12)(13), 46.2% in India (14), 28.4% in Brazil (15), 14.5% in Korea (16), and 35.3% in Thailand (17).…”

Section: Introductionmentioning

confidence: 99%

Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome

Ni¹,

Mo²,

Chen³

et al. 2009

European Journal of Endocrinology

View full text Add to dashboard Cite

Objective: Variations in the prevalence of metabolic syndrome (MetS) among women with polycystic ovary syndrome (PCOS) in different races were reported. We sought to report this prevalence and its components in Chinese women with PCOS and compared these characteristics with healthy controls. Design: Anthropometric measurements and biochemical parameters were evaluated in 578 PCOS patients diagnosed by the Rotterdam criteria and 281 age-and body mass index (BMI)-matched controls. International Diabetes Federation criteria for MetS were used. Results: The prevalence of MetS was 16.8% in this study, and 60.7% of patients displayed at least one component of MetS. Among the patients, the rates of dyslipidemia, impaired fasting glucose, and elevated blood pressure were 41.6, 19.8, and 16.1% respectively; the rates of these corresponding components in age-and BMI-matched controls were 14.6, 5.3, and 5.7% respectively. In PCOS patients, the prevalence of MetS was 0.0, 3.9, 20.2, and 51.1% for four different BMI groups respectively; the prevalence of MetS was 7.3, 14.9, 24.2, and 42.4% in the four age groups respectively. Nearly 90% of patients diagnosed with MetS belonged to overweight and obese groups. BMI and age rather than free testosterone, free androgen index, fasting insulin, or sex hormone-binding globulin were included in formulation for predicting MetS according to multivariable logistic regression. Conclusions: Low prevalence of MetS but high occurrence of various metabolic disorders was found in women with PCOS compared with age-and BMI-matched controls in this study. BMI and age appeared to contribute more to developing MetS than other parameters associated with insulin resistance or hyperandrogenism.

show abstract

“…This PCOS-MS overlap is not singularly met in Caucasian women with PCOS. A highly prevalent MS has also been identified in Brazilian, Chinese, Korean, Indian and in multiracial PCOS populations, at least in overweight/obese patients, in spite of the fact that there are variations in the MS prevalence rates dependent on ethnic/racial regions, age, the diagnostic criteria and the comparison group studied (Fig.1) (Soares et al, 2008;Cheung et al, 2008;Park et al, 2007;Bhattacharya, 2008;Glueck et al, 2003;Apridonidze et al, 2005;Ehrmann et al, 2006;Dokras et al, 2005). Data are presented as %.…”

Section: Metabolic Syndrome In Pcosmentioning

confidence: 99%